+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Diflunisal"

Systemic Lupus Erythematosus Drugs Market 2025-2033 - Product Thumbnail Image

Systemic Lupus Erythematosus Drugs Market 2025-2033

  • Report
  • March 2025
  • 144 Pages
  • Global
From
  • 2 Results (Page 1 of 1)
Loading Indicator

Diflunisal is a non-steroidal anti-inflammatory drug (NSAID) used to treat pain and inflammation associated with immune disorders. It works by blocking the production of certain chemicals in the body that cause inflammation. It is used to treat conditions such as rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis. It is also used to reduce fever and pain caused by other immune disorders. Diflunisal is available in tablet and capsule form and is usually taken twice a day. Diflunisal is generally well tolerated, but side effects may include nausea, vomiting, stomach pain, and diarrhea. It is important to discuss any potential risks with a healthcare provider before taking this medication. The Diflunisal market is a competitive one, with many companies offering products. Some of the companies in the market include Pfizer, Merck, Novartis, and GlaxoSmithKline. Show Less Read more